Skip to main content

Raiffeisen Bank International AG

Bank

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 2044885 VIENNA, C4

Position in BMRN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$801,080
+$10,220 QoQ
Shares Held
14,000
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#300
of 561 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Jun 30, 2026
CallValue
$39,825
CallShares
696
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $103,697,949 across 27 Biotechnology names. BMRN ranks #25 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BMRN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $801,080 14,000
2026-06-30 $39,825 696
2026-03-31 $790,860 14,000
2026-03-31 $39,317 696
2025-12-31 $832,020 14,000
2025-12-31 $41,363 696
2025-09-30 $37,695 696
2025-09-30 $1,554,716 28,706
2025-06-30 $1,290,695 23,480
2025-03-31 $1,543,091 21,829
2024-12-31 $1,029,200 15,658